Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 8-K, Date: 2017-03-31
Original SEC Filing: Click here

---

Webplus: CPHI/20170331/8-K/2_EX-99.1/000.htm SEC Original: ex991.htm
Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results HAIKOU CITY, China, March 31, 2017 – China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma,” the “Company” or “We”), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced

---

---

Webplus: CPHI/20170331/8-K/1/000.htm SEC Original: cphi8k033017.htm

---

Company Info:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 8-K, Date: 2017-03-31CIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216